We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRTX
226
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8.28M 0.11%
113,000
-98,000
-46% -$6.67M
TSCO icon
227
Tractor Supply
TSCO
$16.7B
$8.14M 0.1%
416,115
+16,180
+4% +$294K
AKAM icon
228
Akamai
AKAM
$16.4B
$8.13M 0.1%
113,318
+60,605
+115% +$4.11M
COST icon
229
Costco
COST
$422B
$8.12M 0.1%
33,523
+1,289
+4% +$282K
CEVA icon
230
CEVA Inc
CEVA
$980M
$8.08M 0.1%
299,784
-1,526
-0.5% -$41.4K
LNC icon
231
Lincoln National
LNC
$7.88B
$8.04M 0.1%
137,020
+21,501
+19% +$1.27M
NBL
232
DELISTED
Noble Energy, Inc.
NBL
$8.02M 0.1%
324,167
+159,042
+96% +$3.6M
ITCI
233
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$8.02M 0.1%
658,000
+20,000
+3% +$256K
RARE icon
234
Ultragenyx Pharmaceutical
RARE
$2.65B
$8.01M 0.1%
115,500
– –
AAL icon
235
American Airlines Group
AAL
$9.9B
$7.89M 0.1%
+248,279
New +$8.34M
PSX icon
236
Phillips 66
PSX
$83.3B
$7.85M 0.1%
59,550
-4,455
-7% -$423K
A icon
237
Agilent Technologies
A
$38.9B
$7.84M 0.1%
97,556
-348,302
-78% -$26.4M
PGR icon
238
Progressive
PGR
$125B
$7.68M 0.1%
106,548
+29,336
+38% +$2.01M
VMW
239
DELISTED
VMware, Inc
VMW
$7.61M 0.1%
42,146
-63,377
-60% -$10.3M
STI
240
DELISTED
SunTrust Banks, Inc.
STI
$7.59M 0.1%
128,124
-20,114
-14% -$1.23M
LXFT
241
DELISTED
Luxoft Holding, Inc.
LXFT
$7.47M 0.1%
+127,300
New +$7.24M
CNI icon
242
Canadian National Railway
CNI
$78B
$7.43M 0.1%
82,934
+7,832
+10% +$657K
EA icon
243
Electronic Arts
EA
$52.4B
$7.42M 0.09%
73,005
-67,346
-48% -$6.38M
SUPN icon
244
Supernus Pharmaceuticals
SUPN
$2.73B
$7.36M 0.09%
210,000
+75,000
+56% +$2.79M
BIDU icon
245
Baidu
BIDU
$35.8B
$7.33M 0.09%
44,485
-52,389
-54% -$8.77M
RGA icon
246
Reinsurance Group of America
RGA
$15.7B
$7.26M 0.09%
51,117
-1,753
-3% -$252K
IYR icon
247
iShares US Real Estate ETF
IYR
$4.73B
$7.24M 0.09%
83,137
-1,300
-2% -$108K
FDC
248
DELISTED
First Data Corporation
FDC
$7.24M 0.09%
275,433
+247,956
+902% +$5.89M
QRVO icon
249
Qorvo
QRVO
$7.92B
$7.21M 0.09%
100,580
+40,590
+68% +$2.69M
CTMX icon
250
CytomX Therapeutics
CTMX
$708M
$7.19M 0.09%
668,833
+177,845
+36% +$2.63M
8 9
10
11 12

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.